BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16113458)

  • 1. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids.
    Winkler J; Hochhaus G; Derendorf H
    Proc Am Thorac Soc; 2004; 1(4):356-63. PubMed ID: 16113458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in corticosteroids.
    Hochhaus G
    Proc Am Thorac Soc; 2004; 1(3):269-74. PubMed ID: 16113445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.
    Derendorf H
    J Clin Pharmacol; 2007 Jun; 47(6):782-9. PubMed ID: 17412829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of inhaled corticosteroids: an update.
    Kelly HW
    Ann Pharmacother; 2009 Mar; 43(3):519-27. PubMed ID: 19261959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhaled corticosteroids on long-term growth in pediatric patients with asthma and allergic rhinitis.
    Hoover RM; Erramouspe J; Bell EA; Cleveland KW
    Ann Pharmacother; 2013 Sep; 47(9):1175-81. PubMed ID: 24259733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.
    Bielory L; Blaiss M; Fineman SM; Ledford DK; Lieberman P; Simons FE; Skoner DP; Storms WW; ;
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):514-25. PubMed ID: 16680921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal and inhaled corticosteroids in allergic rhinitis and asthma.
    Lee DK; Lipworth BJ
    Br J Clin Pharmacol; 2004 Oct; 58(4):447-8. PubMed ID: 15373942
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis.
    Blaiss MS
    Allergy Asthma Proc; 2007; 28(2):145-52. PubMed ID: 17479597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unified disease, unified management: treating allergic rhinitis and asthma with nasally inhaled corticosteroid.
    Ribeiro de Andrade C; Chatkin JM; Fiterman J; Scaglia N; Camargos PA
    Respir Med; 2010 Oct; 104(10):1577-80. PubMed ID: 20637586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact allergy to corticosteroids in patients using inhaled or intranasal corticosteroids for allergic rhinitis or asthma.
    Bennett ML; Fountain JM; McCarty MA; Sherertz EF
    Am J Contact Dermat; 2001 Dec; 12(4):193-6. PubMed ID: 11753891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized therapeutic ratio of inhaled corticosteroids using retrometabolism.
    Derendorf H; Hochhaus G; Krishnaswami S; Meibohm B; Möllmann H
    Pharmazie; 2000 Mar; 55(3):223-7. PubMed ID: 10756545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing corticosteroid drugs for pulmonary selectivity.
    Biggadike K; Uings I; Farrow SN
    Proc Am Thorac Soc; 2004; 1(4):352-5. PubMed ID: 16113457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nasal corticosteroids in the treatment of rhinitis.
    Meltzer EO
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):545-60. PubMed ID: 21737042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.
    Derendorf H; Nave R; Drollmann A; Cerasoli F; Wurst W
    Eur Respir J; 2006 Nov; 28(5):1042-50. PubMed ID: 17074919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.
    Rohatagi S; Appajosyula S; Derendorf H; Szefler S; Nave R; Zech K; Banerji D
    J Clin Pharmacol; 2004 Jan; 44(1):37-47. PubMed ID: 14681340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium.
    Lipworth BJ; Jackson CM
    Drug Saf; 2000 Jul; 23(1):11-33. PubMed ID: 10915030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: potential effects on clinical safety and efficacy.
    Hochhaus G
    Clin Ther; 2008 Jan; 30(1):1-13. PubMed ID: 18343239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition and effects of inhaled corticosteroids.
    Newman SP
    Clin Pharmacokinet; 2003; 42(6):529-44. PubMed ID: 12793838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide.
    Gluck PA; Gluck JC
    Curr Med Res Opin; 2005 Jul; 21(7):1075-84. PubMed ID: 16004676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.